Literature DB >> 18602417

Additive interaction between peripheral and central mechanisms involved in the antinociceptive effect of diclofenac in the formalin test in rats.

Mario I Ortiz1, Jair Lozano-Cuenca, Vinicio Granados-Soto, Gilberto Castañeda-Hernández.   

Abstract

It has been proposed that the antinociception of systemic diclofenac is the outcome of peripheral and central actions. Hence, our purpose was to examine if systemic diclofenac is able to achieve effective concentrations at local and spinal sites and to characterize the interaction between its local and spinal actions. Pain was produced in the rat using the formalin test. Oral diclofenac (1-10 mg/kg) reduced formalin-induced pain. The antinociceptive effect of oral diclofenac (10 mg/kg) was abolished by local or spinal administration of either L-NAME (1-100 microg and 1-50 microg) or glibenclamide (12.5-100 microg and 25-75 microg). These results suggest that oral diclofenac achieves effective concentrations producing an antinociceptive effect involving participation of the NO-potassium channel pathway at both, the local and spinal levels. In an additional experimental series, diclofenac was administered either locally (25-200 microg) or spinally (12.5-100 microg), yielding an antinociceptive effect by both routes. Then, diclofenac was given simultaneously by these two routes in a fixed-ratio, and antinociception was assayed. Isobolographic analysis revealed an additive interaction between the local and spinal effects of diclofenac. Hence, our results provide evidence that the overall antinociceptive effect induced by systemic diclofenac is the outcome of central and peripheral mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602417     DOI: 10.1016/j.pbb.2008.06.008

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  Role of pertussis toxin-sensitive G-protein, K+ channels, and voltage-gated Ca2+ channels in the antinociceptive effect of inosine.

Authors:  Sérgio José Macedo-Junior; Francisney Pinto Nascimento; Murilo Luiz-Cerutti; Adair Roberto Soares Santos
Journal:  Purinergic Signal       Date:  2012-07-18       Impact factor: 3.765

2.  Semi-mechanistic modeling of the interaction between the central and peripheral effects in the antinociceptive response to lumiracoxib in rats.

Authors:  Nieves Vélez de Mendizábal; Dalia Vásquez-Bahena; Juan M Jiménez-Andrade; Mario I Ortiz; Gilberto Castañeda-Hernández; Iñaki F Trocóniz
Journal:  AAPS J       Date:  2012-09-12       Impact factor: 4.009

3.  Synergistic interaction between metformin and sulfonylureas on diclofenac-induced antinociception measured using the formalin test in rats.

Authors:  Mario I Ortiz
Journal:  Pain Res Manag       Date:  2013-08-28       Impact factor: 3.037

4.  Diclofenac causes more leakage than naproxen in anastomoses in the small intestine of the rat.

Authors:  R J van der Vijver; C J H M van Laarhoven; R M L M Lomme; T Hendriks
Journal:  Int J Colorectal Dis       Date:  2013-02-10       Impact factor: 2.571

5.  Evaluation of the neonatal streptozotocin model of diabetes in rats: Evidence for a model of neuropathic pain.

Authors:  Paulino Barragán-Iglesias; Víctor Hugo Oidor-Chan; Emanuel Loeza-Alcocer; Jorge Baruch Pineda-Farias; Isabel Velazquez-Lagunas; Ana Belen Salinas-Abarca; Enrique Hong; Alicia Sánchez-Mendoza; Rodolfo Delgado-Lezama; Theodore J Price; Vinicio Granados-Soto
Journal:  Pharmacol Rep       Date:  2017-09-14       Impact factor: 3.024

6.  Evidence for the Participation of ATP-sensitive Potassium Channels in the Antinociceptive Effect of Curcumin.

Authors:  Marco Antonio De Paz-Campos; Aracely Evangelina Chávez-Piña; Mario I Ortiz; Gilberto Castañeda-Hernández
Journal:  Korean J Pain       Date:  2012-10-04

7.  Opioid Mechanism Involvement in the Synergism Produced by the Combination of Diclofenac and Caffeine in the Formalin Model.

Authors:  José María Flores-Ramos; M Irene Díaz-Reval
Journal:  ISRN Pain       Date:  2013-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.